Mission Driven to Advance Medical Device Safety and Innovation

NAMSA started from modest roots as a small medical device testing lab in 1967. Today we serve more than 3,000 companies each year, offering a full spectrum of medical device testing, preclinical/clinical research, and regulatory compliance consulting. Our goal then, as now, is to advance the safety of medical devices for patients and users and to help our clients bring life-saving new medical technologies to market. Our team of 1,400+ scientists, technicians, and consultants are dedicated to delivering clients with strategic guidance and tactical support to fast-track commercialization and make an immediate impact on patient care.

NAMSA Values

Since 1967, NAMSA has grown, but the values that defined us from the start are those that still guide us today. NAMSA’s modest roots in medical device laboratory operations in the 1960s and 1970s have evolved to help clients develop and deliver innovative medical products in every area of the world. We do this by providing the full continuum of development solutions, which includes medical device testing, regulatory, reimbursement and quality consulting, as well as clinical research services. Our team of more than 1,700 experienced Associates are passionately dedicated to delivering clients with strategic guidance and tactical support to fast-track commercialization and make a more immediate impact on patient healthcare worldwide.

Vision: Inspire innovative MedTech solutions that advance global healthcare, improve patient lives, and accelerate Client success.

Mission: Deliver best-in-class global MedTech solutions through our people, expertise, and technology.

Our Guiding Principles

Act with integrity in everything we do
Provide best-in-class customer experiences
Develop superior talent and deliver expertise
Respond with agility and provide timely results
Embrace collaboration, diverse perspectives, and ideas

50% of All New High-Risk Medical Innovations Come Through NAMSA

Manufacturers spend years and tens of millions to get a new medical device to market, so working with experienced partners is a must. That’s why more than half of all new FDA Premarket Approvals for innovative high-risk devices are entrusted to NAMSA for testing or clinical research every year. We assist in the following areas:

All Services

From Startups to Multinationals, Companies Place Their Trust In Us

Learn More About NAMSA

Leadership Team

NAMSA Certifications

Company Locations

Events We Attend

Work for NAMSA

Company History

Serving 3,000+ Medical Device and IVD Companies Worldwide

Through our offices in the US, Germany, France, Belgium, Spain and Japan, NAMSA supports companies from more than 50 countries around the globe.

See Our Locations

NAMSA Facilities Areas We Serve

Deep Expertise in Numerous Categories

NAMSA tested nearly 120,000 devices last year so we’ve seen nearly every combination of technologies. We also have extensive preclinical and clinical experience in a wide variety of device categories.

Cardiovascular

Neurovascular